Fusobacterium Detected in Barrett’s Esophagus and Esophageal Adenocarcinoma Tissues

References

• Gavin AT, Francisci S, Foschi R, Donnelly DW, Lemmens V, Brenner H, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505–512.
   PubMed Web of Science ®Google Scholar
• Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–146. doi:10.1093/jnci/dji024.
   PubMed Web of Science ®Google Scholar
• Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136(2):376–386. doi:10.1053/j.gastro.2008.12.015.
   PubMed Web of Science ®Google Scholar
• Tachimori Y, Ozawa S, Numasaki H, Fujishiro M, Matsubara H, Oyama T, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2006. Esophagus. 2014;11(1):21–47. doi:10.1007/s10388-013-0393-5.
   Web of Science ®Google Scholar
• Masuda M, Kuwano H, Okumura M, Amano J, Arai H, Endo S, et al. Thoracic and cardiovascular surgery in Japan during 2012: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2014;62(12):734–764. doi:10.1007/s11748-014-0464-0.
   PubMedGoogle Scholar
• Spechler SJ, Goyal RK. Barrett’s esophagus. N Engl J Med. 1986;315(6):362–371. doi:10.1056/NEJM198608073150605.
   PubMed Web of Science ®Google Scholar
• Barrett NR. The lower esophagus lined by columnar epithelium. Surgery. 1957;41(6):881–894.
   PubMed Web of Science ®Google Scholar
• Caygill CP, Royston C, Charlett A, Wall CM, Gatenby PA, Ramus JR, et al. Mortality in Barrett’s esophagus: three decades of experience at a single center. Endoscopy. 2012;44(10):892–898. doi:10.1055/s-0032-1309842.
   PubMedGoogle Scholar
• Rostami Nejad M, Ishaq S, Al Dulaimi D, Zali MR, Rostami K. The role of infectious mediators and gut microbiome in the pathogenesis of celiac disease. Arch Iran Med. 2015;18(4):244–249.
   PubMed Web of Science ®Google Scholar
• Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut. 2003;52(1):79–83. doi:10.1136/gut.52.1.79.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489–1499. doi:10.1053/j.gastro.2014.02.009.
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–1023. doi:10.1038/4441022a.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–867. doi:10.1038/nature05485.
   PubMed Web of Science ®Google Scholar
• Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012;3(4):279–288. doi:10.4161/gmic.19625.
   PubMed Web of Science ®Google Scholar
• Fujimura KE, Lynch SV. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe. 2015;17(5):592–602. doi:10.1016/j.chom.2015.04.007.
   PubMed Web of Science ®Google Scholar
• Vogtmann E, Goedert JJ. Epidemiologic studies of the human microbiome and cancer. Br J Cancer. 2016;114(3):237–242. doi:10.1038/bjc.2015.465.
   PubMed Web of Science ®Google Scholar
• Garrett WS. Cancer and the microbiota. Science. 2015;348(6230):80–86. doi:10.1126/science.aaa4972.
   PubMed Web of Science ®Google Scholar
• Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent inhuman colorectal carcinoma. Genome Res. 2012;22:299–306.
   PubMed Web of Science ®Google Scholar
• Tahara T, Yamamoto E, Suzuki H, Maruyama R, Chung W, Garriga J, et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 2014;74(5):1311–1318. doi:10.1158/0008-5472.CAN-13-1865.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–215. doi:10.1016/j.chom.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its fadA adhesin. Cell Host Microbe. 2013;14(2):195–206. doi:10.1016/j.chom.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, et al. Human microbiome fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res. 2016;22(22):5574–5581. doi:10.1158/1078-0432.CCR-16-1786.
   PubMed Web of Science ®Google Scholar
• Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol. 2011;13(2):25–36.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Dörffel Y, Loening-Baucke V, Theissig F, Rückert JC, Ismail M, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut. 2011;60(1):34–40. doi:10.1136/gut.2009.191320.
   PubMed Web of Science ®Google Scholar
• Sharma P, Morales TG, Sampliner RE. Short segment Barrett’s esophagus – the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998;93(7):1033–1036. doi:10.1111/j.1572-0241.1998.00324.x.
   PubMed Web of Science ®Google Scholar
• Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis, a progress report on observer agreement. Gastroenterology. 1996;111(1):85–92. doi:10.1053/gast.1996.v111.pm8698230.
   PubMed Web of Science ®Google Scholar
• Shijimaya T, Tahara T, Yamazaki J, Matsumoto Y, Nakamura N, Takahashi Y, et al. Comprehensive DNA methylation profiling of Barrett’s esophagus and esophageal adenocarcinoma in Japanese patients. Mol Carcinog. 2023;62:1191–1200.
   PubMed Web of Science ®Google Scholar
• Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH. Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS Immunol Med Microbiol. 2005;45(2):191–199. doi:10.1016/j.femsim.2005.03.011.
   PubMedGoogle Scholar
• Wilson GM, Flibotte S, Chopra V, Melnyk BL, Honer WG, Holt RA. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum Mol Genet. 2006;15(5):743–749. doi:10.1093/hmg/ddi489.
   PubMed Web of Science ®Google Scholar
• Tahara T, Shijimaya T, Yamazaki J, Tomiyama T, Fukui T, Naganuma M. Telomere shortening of Barrett’s esophagus and esophageal adenocarcinoma in Japanese patients. Cancer Invest. 2023;41(7):640–645. doi:10.1080/07357907.2023.2245897.
   PubMed Web of Science ®Google Scholar
• Shijimaya T, Tahara T, Yamazaki J, Kobayashi S, Horitani A, Matsumoto Y, et al. Microarchitectures of Barrett’s esophagus associated with DNA methylation status. Epigenomics. Epigenomics. 2023;15(15):759–767. doi:10.2217/epi-2023-0214.
   PubMed Web of Science ®Google Scholar
• Elliott DRF, Walker AW, O’Donovan M, Parkhill J, Fitzgerald RC. A non-endoscopic device to sample the oesophageal microbiota: a case-control study. Lancet Gastroenterol Hepatol. 2017;2(1):32–42. doi:10.1016/S2468-1253(16)30086-3.
   PubMed Web of Science ®Google Scholar
• Lopetuso LR, Severgnini M, Pecere S, Ponziani FR, Boskoski I, Larghi A, et al. Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma. PLoS One. 2020;15(5):e0231789. doi:10.1371/journal.pone.0231789.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Fujisaki J, Omae M, Yamasaki A, Horiuchi Y, Ishiyama A, et al. Treatment outcomes of endoscopic submucosal dissection for adenocarcinoma originating from long-segment Barrett’s Esophagus versus short-segment Barrett’s esophagus. Digestion. 2018;97(4):316–323. doi:10.1159/000486197.
   PubMed Web of Science ®Google Scholar
• Koike T, Nakagawa K, Iijima K, Shimosegawa T. Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett’s esophageal cancer. Dig Endosc. 2013;25(S1):20–28. doi:10.1111/den.12047.
   PubMedGoogle Scholar
• Chandrasekar VT, Hamade N, Desai M, Rai T, Gorrepati VS, Jegadeesan R, et al. Significantly lower annual rates of neoplastic progression in short- compared to long-segment non-dysplastic Barrett’s esophagus: a systematic review and meta-analysis. Endoscopy. 2019;51(7):665–672. doi:10.1055/a-0869-7960.
   PubMed Web of Science ®Google Scholar
• Nomoto D, Baba Y, Liu Y, Tsutsuki H, Okadome K, Harada K, et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway. Cancer Lett. 2022;530:59–67.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association, American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):e18–52quiz–e13. doi:10.1053/j.gastro.2011.01.031.
   Web of Science ®Google Scholar